Flowflex Launches First FDA-Cleared 4-in-1 Home Test Detecting RSV, Flu A/B and COVID for Ages 6 Months+
SAN DIEGO, CA., January 22, 2026 — ACON Laboratories, Inc. today announced the retail availability of the first FDA-cleared home test which allows families to identify four major respiratory infections, including Respiratory Syncytial Virus (RSV), in adults and children as young as 6 months using a single test. The Flowflex® Plus RSV + Flu A/B + COVID 4-in-1 test empowers consumers to quickly identify the cause of symptoms such as fever, cough, congestion, and wheezing. The ability to test infants for RSV is especially significant because RSV is the leading cause of hospitalization in young children, as referenced by the U.S. Centers for Disease Control and Prevention (CDC). For parents and caregivers, the ability to distinguish between RSV, Flu, and